From a cellular pharmacy viewpoint, Naproxol represents a intricate case study. Its mechanism of effect involves the preferential inhibition of cyclooxygenase enzymes, specifically the enzyme , although with a measure of non-selectivity compared to newer agents. This produces a decrease of pain-s